Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer
Objectives: The proliferative activity of the Ki-67 index is important in decision-making of adjuvant treatments in early breast cancer. Its reliability can be reduced by inter-observer variability. This analysis’ objective is to evaluate the robustness of Ki-67 values within one center over 5 years...
Main Authors: | Angela Fischer Maranta, Simon Broder, Constanze Fritzsche, Michael Knauer, Beat Thürlimann, Wolfram Jochum, Thomas Ruhstaller |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977620300849 |
Similar Items
-
MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
by: Dorsay Sadeghian, et al.
Published: (2022-02-01) -
Ki-67 protein: a proliferation index in breast cancer
by: Shervin Kheirandish, et al.
Published: (2015-10-01) -
Ki-67 protein: a proliferation index in breast cancer
by: Shervin Kheirandish, et al.
Published: (2015-09-01) -
EVALUATION OF P53 AND KI67 PROLIFERATIVE INDEX IN TRIPLE NEGATIVE BREAST CARCINOMA
by: Farhan AKhtar, et al.
Published: (2020-02-01) -
Relationship Between SUVmax and Ki-67 Expression in Breast Cancer
by: Meriç Emre Bostancı, et al.
Published: (2020-09-01)